Celltrion
068270.KS
#815
Rank
A$44.27 B
Marketcap
A$193.04
Share price
-0.31%
Change (1 day)
4.66%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): A$3.78

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$3.53. In 2025 the company made an earnings per share (EPS) of A$4.32 an increase over its 2024 EPS that were of A$1.64.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.78-12.33%
2025A$4.32163.66%
2024A$1.64-53.73%
2023A$3.54-2.08%
2022A$3.61-11.72%
2021A$4.092.03%
2020A$4.0182.8%
2019A$2.1918.31%
2018A$1.85-36.33%
2017A$2.91161.25%
2016A$1.112.86%
2015A$1.0817.84%
2014A$0.925.87%
2013A$0.87-70.85%
2012A$2.98134.09%
2011A$1.2743.59%
2010A$0.8974.49%
2009A$0.51317.8%
2008A$0.12-71.7%
2007A$0.43